LCSBi008-A-1

delP GC13, DJ-1-delP GC13

General

Cell Line

hPSCreg Name
LCSBi008-A-1
Alternative name(s)
delP GC13, DJ-1-delP GC13
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 4th April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Luxembourg Centre for Systems Biomedicine (LCSB)

External Databases

BioSamples SAMEA13914317
CLO CLO_0103882
Cellosaurus CVCL_C0JA
Wikidata Q112929993

General Information

Publications
* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Parkinson's Disease
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease

External Databases (Donor)

BioSamples SAMEA13793663

Ethics

Also have a look at the ethics information for the parental line LCSBi008-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line LCSBi008-A.

Reprogramming method

Vector type Non-integrating
Vector Episomal

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
NANOG
Yes
SOX2
Yes
POU5F1 (OCT-4)
Yes
DNMT3B
Yes
Morphology pictures

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XY

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Parkinson's Disease
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease
Genetic modifications
PARK7 (target)
Isogenic modification
Homozygous
Repaired
Genetic modifications not related to a disease